Weekly Roundup: November 16-20

In case you missed it, some of this week’s featured content includes a new episode of our podcast, The Cutaneous Connection, tackling racial disparities in melanoma awareness with Neelam Vashi, M.D., FAAD. Also, stories on psoriatic arthritis, practice management, advances in body contouring, caffeine’s role in skincare, smartphone apps and skin cancer detection, how to choose the right cosmetic neuromodulator, plus more.

POLL: Do you think live in-person medical conferences will return in 2021?

Nonprescription topical ivermectin approved for head lice

Ivermectin 0.5% lotion (Sklice, Arbor Pharmaceuticals) is now approved by the U.S. Food and Drug Administration (FDA) for nonprescription use to treat head lice.

Guselkumab reduces fatigue in PsA patients

Studies confirm improvement achieved and maintained through one year of active treatment with similar scores for patients switching from placebo to guselkumab.

COVID-19 study shows impact on patients with PsO, other autoimmune problems

Ardon Health patients with autoimmune conditions have expressed common questions and concerns about COVID-19.

The Mainstream Patient: November 16

This week’s edition of The Mainstream Patient features stories on skincare in dermatology clinics, exfoliation during the winter, crying and acne breakouts, plus more.

What You Don’t Know and Should Know About Passwords

J.D. Norcross, director of information technology at VitalSkin Dermatology, discusses some myths and best practices with digital passwords you should know to help keep your practice information safer.

Selling Your Practice: Leading Change When Transitioning

Todd Petersen, CEO of VitalSkin Dermatology, discusses how to best lead your team through change when selling and transitioning your practice.

Smartphone apps not effective in skin cancer risk

Researchers conducted a critical appraisal of a systematic review of six different smartphone apps and found little evidence that they are effective in self-monitoring or skin cancer detection, according to a recent study.

Recipients to be honored at virtual 2020 Giants of Dermatology awards

Six recipients will be announced and recognized as this year’s Giants of Dermatology honorees in a virtual gala to be held in early December.

Gene expression profile test predicts metastatic risk

Investigators of a recent study found a 40-gene expression profile (40-GEP) test helps improve identification of high risk for metastatic disease in patients with cutaneous squamous cell carcinoma (cSCC).

Robotic-controlled laser advances body contouring

A novel robotic-controlled 1064-nm laser brings efficiency and precision to body contouring. The clinical trial supporting FDA clearance of the device showed its effectiveness based on blinded photographic assessments, ultrasound measurements and circumferential assessments.

Future of immunotherapy in melanoma to focus on overcoming resistance, personalizing regimens

With an estimated 5-year survival rate of 50% and an ongoing issue of resistance, next steps with immunotherapy in melanoma will focus on stratifying patients, personalizing therapy, and refining localized regimens.

The Cutaneous Connection- Episode 11: Racial Disparities in Melanoma Awareness

Neelam Vashi, M.D., FAAD, discusses the publication of her cross-sectional survey in the Journal of the American Academy of Dermatology regarding how different racial and ethnic groups possess various levels of melanoma awareness.

Strategies for choosing and using neuromodulators

All safe and effective, the four neuromodulators with cosmetic indications have nuanced differences worth considering. Seth Matarasso, M.D., explains the benefits of these cosmetic neuromodulators, and reveals how to know when to choose the right one.

Caffeine's role in skincare

Caffeine holds certain properties that may benefit the skin. As an antioxidant, it may decrease the production of reactive oxygen species and free radicals as well as damage from ultraviolet radiation. It may even play a role in promoting hair growth.